Every 10-Q that Sono-Tek Corporation (SOTK) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow SOTK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SOTK filings page.
Sono-Tek Corporation reported higher results for the first quarter of fiscal 2027. Net sales rose to $5,661,000 from $5,133,000, a 10% increase, driven largely by strong medical market shipments, including specialty stent and drug-eluting balloon coating systems. Gross profit improved to $3,214,000, with margin expanding to 57% from 52%, helped by a favorable product mix and more U.S.-based sales.
Net income increased to $741,168, or $0.05 per diluted share, compared with $484,985, or $0.03 per share, a year earlier. Medical market revenue grew sharply while alternative energy sales declined after a large prior-year solar order. Cash, cash equivalents and marketable securities totaled $16,652,000 with no outstanding debt, and combined equipment and service-related backlog was $7.73 million, slightly above the prior year. About 38% of sales came from customers outside the United States and Canada.
Sono-Tek Corporation reported improved profitability for its third quarter of fiscal 2026 despite nearly flat sales. Net sales for the quarter were $5.0 million, down 3.6% from $5.19 million a year earlier, but gross margin expanded to 50% from 45% as product mix shifted toward higher-margin systems and U.S. sales with lower distributor discounts. Operating income rose to $319,000, up 61% from $198,000, and net income increased 24% to $340,000.
For the first nine months of fiscal 2026, revenue was essentially flat at $15.3 million, while net income grew 32% to $1.25 million as gross profit improved to $7.77 million and gross margin reached 51%. The company ended the period with no debt and cash, cash equivalents and marketable securities totaling $12.26 million, and reported a record combined equipment and service backlog of $12.26 million, up 16% year over year. Shares outstanding were 15,710,389 as of January 9, 2026.
Sono-Tek (SOTK) reported Q2 FY26 results with net sales of $5,163,000 and diluted EPS of $0.03. Gross profit was $2,590,000 with a 50.2% gross margin. Operating income rose to $421,000, a 47% increase year over year as higher-margin mix and lower operating expenses helped results.
Medical sales grew 150% on balloon coating shipments, while Alternative/Clean Energy was steady and Electronics/Microelectronics held near prior-year levels. APAC revenue increased 153% driven by medical and energy orders, partially offsetting a 22% decline in the U.S. and Canada. Backlog was $11,210,000 at August 31, 2025, up 50% sequentially from Q1.
For the first half, sales were $10,296,000 and operating income $905,000 (up 73%). Cash, cash equivalents and marketable securities totaled $10,568,000 with no outstanding debt. Operating cash flow was $(1,099,000), reflecting higher accounts receivable tied to revised timing on a $4.4 million multi-unit order.